Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions…

Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Scores

EPSS (exploitation in 30 days)

2.9% · top 13% of all CVEs (4 Nov 2026)

The list uses the assigner's score when there is one, then CISA's, then NVD's: Critical 9.4.

Weakness

• CWE-287: Improper Authentication cwe-287 (opens in a new tab)All about CWE-287 and its CVEs

Affected products

• Becton, Dickinson and Company · Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA

  • affected Version 2.3.6 and prior

References (3)

• 105147 (opens in a new tab)vdb-entryx_refsource_BIDx_transferred
• http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states (opens in a new tab)x_refsource_CONFIRMx_transferred
• https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 (opens in a new tab)x_refsource_MISCx_transferred

Sources

The same CVE in the primary databases and aggregators, to check against.

• CVE.org record (opens in a new tab)
• CVE List JSON (GitHub) (opens in a new tab)
• NVD (opens in a new tab)
• FIRST EPSS (opens in a new tab)
• OSV.dev (opens in a new tab)
• GitHub Advisories (opens in a new tab)
• CIRCL Vulnerability-Lookup (opens in a new tab)

Badge for a README or a ticket

[![CVE-2018-14786](https://trackcve.app/badge/CVE-2018-14786.svg)](https://trackcve.app/cve/CVE-2018-14786)

Record last updated 17 Sept 2024, 04:14 UTC.